MENU
PTCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PTC Therapeutics (PTCT) Ownership - Who owns PTC Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.63B
P/E Ratio
N/A
Total Cash
1.01B
Projected Growth
N/A
Total Debt
400.21M
Revenue
900.66M
Risk (Beta)
0.54
Dividend Yield
N/A
Total Cash/Share
13.14
Total Debt/Equity
0.01
Revenue/Share
11.79 USD as % of share price
Fundamentals
PTCT
Capitalization
3.63B
P/E Ratio
N/A
Risk (Beta)
0.54
Dividend Yield
N/A
Total Cash
1.01B
Total Cash/Share
13.14
Total Debt
400M
Total Debt/Equity
0.01
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
11.79%
Revenue
901M
ROE
N/A
Book Value
-1.05B
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-5.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
76K
Current Ratio
2.10
Current Revenue Per Employee
197774.88
Dividends Per Share - Security
N/A
EBITDA
-105.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
94.49
Revenue To Assets
-29.22
Shares Held By Institutions
5.47B
Shares Outstanding - Current
77.1M
Total Liabilities
2.9B
Total Volume MTD
N/A
Value
-1
Gain YTD
70.610
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com